Process View
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of nitric oxide biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.959 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.893 | ||
| EGFR | epidermal growth factor receptor | 0.866 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.580 | ||
| IL8 | interleukin 8 | 0.540 | ||
| ESR1 | estrogen receptor 1 | 0.373 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.312 | ||
| INSR | insulin receptor | 0.171 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.138 | ||
| JUN | jun proto-oncogene | 0.131 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.121 | Human | |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.112 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.103 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.096 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.089 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.087 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.077 | ||
| IL1B | interleukin 1, beta | 0.077 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.076 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.065 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.064 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.049 | ||
| KLF6 | Kruppel-like factor 6 | 0.047 | Human | |
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.041 | ||
| PRKCZ | protein kinase C, zeta | 0.039 | Human | |
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.039 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.035 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.034 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.033 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.029 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.028 | ||
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.028 | ||
| MPDZ | multiple PDZ domain protein | 0.028 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.028 | ||
| MYLK2 | myosin light chain kinase 2 | 0.026 | ||
| APP | amyloid beta (A4) precursor protein | 0.023 | ||
| CTBP1 | C-terminal binding protein 1 | 0.023 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.023 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.023 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.022 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.022 | ||
| SSTR2 | somatostatin receptor 2 | 0.022 | Human | |
| PPP5C | protein phosphatase 5, catalytic subunit | 0.021 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.021 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.020 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.019 | Human | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.019 | ||
| PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.019 | ||
| PRKCB | protein kinase C, beta | 0.018 | ||
| XPO7 | exportin 7 | 0.016 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.015 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.014 | ||
| IER2 | immediate early response 2 | 0.014 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.014 | ||
| BAD | BCL2-associated agonist of cell death | 0.013 | ||
| LY96 | lymphocyte antigen 96 | 0.013 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.013 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.013 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.012 | ||
| JAK1 | Janus kinase 1 | 0.012 | ||
| SSTR3 | somatostatin receptor 3 | 0.012 | Human | |
| NCF1 | neutrophil cytosolic factor 1 | 0.012 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.012 | ||
| CDCP1 | CUB domain containing protein 1 | 0.012 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.012 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.012 | ||
| RHOB | ras homolog gene family, member B | 0.011 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.010 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.010 |